Eugene Chang

Eugene Chang

Auto-generated profile, based on publicly available information

Eugene Chang

Department of Supportive Care Princess Margaret Cancer Centre Toronto Canada

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in Current Oncology
Verified
Journal Article
Open access
DMDaniel Santa Mina
Daniel Santa Mina
CSC.M. Sabiston
C.M. Sabiston
DAD. Au
D. Au
AFAngela J. Fong
Angela J. Fong
LCL.C. Capozzi
L.C. Capozzi
SCS.N. Culos-Reed
S.N. Culos-Reed
Recent guidelines concerning exercise for people with cancer provide evidence-based direction for exercise assessment and prescription for clinicians and their patients. Although the guidelines promote exercise integration into clinical care for people with cancer, they do not support strategies for bridging the guidelines with related resources or programs. Exercise program accessibility remains a challenge in implementing the guidelines, but that challenge might be mitigated with conceptual frameworks (“pathways”) that connect patients with exercise-related resources. In the present paper, we describe a pathway model and related resources that were developed by an expert panel of practitioners and researchers in the field of exercise and rehabilitation in oncology and that support the transition from health care practitioner to exercise programs or services for people with cancer. The model acknowledges the nuanced distinctions between research and exercise programming, as well as physical activity promotion, that, depending on the available programming in the local community or region, might influence practitioner use. Furthermore, the pathway identifies and provides examples of processes for referral, screening, medical clearance, and programming for people after a cancer diagnosis. The pathway supports the implementation of exercise guidelines and should serve as a model of enhanced care delivery to increase the health and well-being of people with cancer.

25 September 2020 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
PBPriya Brahmbhatt
Priya Brahmbhatt
CSCatherine M. Sabiston
Catherine M. Sabiston
CLChristian Lopez
Christian Lopez
ECEugene Chang
Eugene Chang
JGJack Goodman
Jack Goodman
DMDaniel Santa Mina
Daniel Santa Mina
Background: Breast cancer surgery results in numerous acute and long-term adverse outcomes; the degree to which these can be mitigated or prevented through prehabilitation is unknown. Methods: We conducted a longitudinal, single-arm, mixed-methods study to examine the feasibility of prehabilitation in 22 women undergoing breast cancer surgery. All participants received an individualized exercise prescription including upper quadrant-specific resistance and mobility training and aerobic exercise for the duration of their surgical wait time. Feasibility was assessed by recruitment, adherence, attrition, and intervention-related adverse event rates. An exploratory investigation of intervention efficacy was conducted via a 6-min walk test, upper-quadrant strength and range of motion, volumetric chances associated with lymphedema, and participant-reported quality of life, fatigue, pain, and disability. Outcome assessments were conducted at baseline, prior to surgery, and at six and 12 weeks after surgery. Semi-structured interviews with a subset of participants (n = 5) and health-care providers (H; n = 2) were conducted to provide further insights about intervention feasibility. Qualitative data were analyzed using a hybrid inductive and deductive thematic analysis approach. Results: Recruitment and attrition rates were 62 and 36%, respectively. Average prehabilitation duration was 31 days (range = 7–69 days). Seventy six percent of participants complied with at least 70% of their prehabilitation prescription. There was a clinically significant increase in the 6-min walk distance from baseline to the preoperative assessment (57 m, 95% CI = −7.52, 121.7). The interviews revealed that the intervention was favorably received by participants and HCPs and included suggestions that prehabilitation (i) should be offered to all surgical candidates, (ii) is an avenue to regain control in the preoperative period, (iii) is a facilitator of postoperative recovery, and (iv) is an opportunity to provide education regarding postoperative rehabilitation protocols. A preference for multimodal prehabilitation (including dietetic and psychological counseling) was also highlighted. Conclusion: Our findings suggest that surgical prehabilitation in women with breast cancer is feasible. Data are hampered by study sample size and lack of a control group. Thus, randomized controlled trials to examine prehabilitation efficacy in people with breast cancer, especially interventions employing a multimodal strategy, are warranted.

5 February 2016 in Cancer
Verified
Journal Article
Open access
PDF file
AGAbha Gupta
Abha Gupta
JPJanet K. Papadakos
Janet K. Papadakos
JJJennifer M. Jones
Jennifer M. Jones
LALeila Amin
Leila Amin
ECEugene K. Chang
Eugene K. Chang
MGMeredith Giuliani
Meredith Giuliani
Literature regarding the development of adolescent and young adult (AYA) cancer programs has been dominantly informed by pediatric centers and practitioners. However, the majority of young adults are seen and treated at adult cancer centers, in which cancer volumes afford the development of innovative supportive care services. Although the supportive care services in adult cancer centers are helpful to AYAs, some of the most prominent and distinct issues faced by AYAs are not adequately addressed through these services alone. This article describes how the AYA Program at Princess Margaret Cancer Centre has collaborated with existing supportive care services in addition to supplying its own unique services to meet the comprehensive needs of AYAs in the domains of: symptom management (sexuality and fatigue), behavior modification (return to work and exercise), and health services (advanced cancer and survivorship). These collaborations are augmented by patient education interventions and timely referrals. The objective of this article was to assist other centers in expanding existing services to address the needs of AYA patients with cancer. Cancer 2016;122:1038–1046. © 2016 American Cancer Society

1 September 2018 in The Lancet Oncology
Verified
Journal Article
Closed access
DMDaniel Santa Mina
Daniel Santa Mina
David Michael LangelierDavid Michael Langelier
David Michael Langelier
SAScott C Adams
Scott C Adams
SAShabbir M H Alibhai
Shabbir M H Alibhai
MCMartin Chasen
Martin Chasen
ECEugene Chang
Eugene Chang

17 June 2019 in Cancer
Verified
Journal Article
Closed access
PDF file
DMDaniel Santa Mina
Daniel Santa Mina
DADarren Au
Darren Au
LALeslie E. Auger
Leslie E. Auger
SAShabbir Alibhai
Shabbir Alibhai
AMAndrew G. Matthew
Andrew G. Matthew
JJJennifer M. Jones
Jennifer M. Jones

1 September 2017 in Thyroid®
Verified
Journal Article
Closed access
AAAhmad Alhashemi
Ahmad Alhashemi
JJJennifer M. Jones
Jennifer M. Jones
DGDavid P. Goldstein
David P. Goldstein
DMDaniel Santa Mina
Daniel Santa Mina
LTLehana Thabane
Lehana Thabane
ASAnna M. Sawka
Anna M. Sawka
Background: Fatigue is common among cancer survivors, but fatigue in thyroid cancer (TC) survivors may be under-appreciated. This study investigated the severity and prevalence of moderate and severe fatigue in TC survivors. Potential predictive factors, including physical activity, were explored. Methods: A cross-sectional, written, self-administered TC patient survey and retrospective chart review were performed in an outpatient academic Endocrinology clinic in Toronto, Canada. The primary outcome measure was the global fatigue score measured by the Brief Fatigue Inventory (BFI). Physical activity was evaluated using the International Physical Activity Questionnaire—7 day (IPAQ-7). Predictors of BFI global fatigue score were explored in univariate analyses and a multivariable linear regression model. Results: The response rate was 63.1% (205/325). Three-quarters of the respondents were women (152/205). The mean age was 52.5 years, and the mean time since first TC surgery was 6.8 years. The mean global BFI score was 3.5 (standard deviation 2.4) out of 10 (10 is worst). The prevalence of moderate-severe fatigue (global BFI score 4.1–10 out of 10) was 41.4% (84/203). Individuals who were unemployed or unable to work due to disability reported significantly higher levels of fatigue compared to the rest of the study population, in uni-and multivariable analyses. Furthermore, increased physical activity was associated with reduced fatigue in uni- and multivariable analyses. Other socio-demographic, disease, or biochemical variables were not significantly associated with fatigue in the multivariable model. Conclusions: Moderate or severe fatigue was reported in about 4/10 TC survivors. Independent predictors of worse fatigue included unemployment and reduced physical activity.